The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
A Cytoplasmic ATM-TRAF6-cIAP1 Module Links Nuclear DNA Damage Signaling to Ubiquitin-Mediated NF-κB Activation
Open accessAbstract
As part of the genotoxic stress response, cells activate the transcription factor NF-κB. The DNA strand break sensor poly(ADP-ribose)-polymerase-1 (PARP-1) and the kinase ataxia telangiectasia mutated (ATM) act as proximal signal mediators. PARP-1 assembles a nucleoplasmic signalosome, which triggers PIASy-mediated IKKγ SUMOylation. ATM-dependent IKKγ phosphorylation and subsequent ubiquitination were implicated to activate the cytoplasmic IκB kinase (IKK) complex by unknown mechanisms. We show that activated ATM translocates in a calcium-dependent manner to cytosol and membrane fractions. Through a TRAF-binding motif, ATM activates TRAF6, resulting in Ubc13-mediated K63-linked polyubiquitin synthesis and cIAP1 recruitment. The ATM-TRAF6-cIAP1 module stimulates TAB2-dependent TAK1 phosphorylation. Both nuclear PARP-1- and cytoplasmic ATM-driven signaling branches converge at the IKK complex to catalyze monoubiquitination of IKKγ at K285. Our data indicate that exported SUMOylated IKKγ acts as a substrate. IKKγ monoubiquitination is a prerequisite for genotoxic IKK and NF-κB activation, but also promotes cytokine signaling.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Subsequent studies confirmed that following DSB induction, activated ATM couples with a number of protein intermediates leading to its cytoplasmic transport and downstream activation of NF‐kB (Hinz et al, 2010; Wu et al, 2010; Miyamoto, 2011).”
From Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease (2022) · cites this paper as Hinz et al, 2010
Citations
Cites
Cox, J., & Mann, M. (2008) · Nature Biotechnology · doi:10.1038/nbt.1511 · Cited by 14,855
The DNA-damage response in human biology and disease
Jackson, S. P., & Bartek, J. (2009) · Nature · doi:10.1038/nature08467 · Cited by 6,092
Shared Principles in NF-κB Signaling
Hayden, M. S., & Ghosh, S. (2008) · Cell · doi:10.1016/j.cell.2008.01.020 · Cited by 4,954
Schreiber, E. H., Matthias, P., Müller, M. M., & Schaffner, W. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.15.6419 · Cited by 4,179
Genome maintenance mechanisms for preventing cancer
Hoeijmakers, J. H. J. (2001) · Nature · doi:10.1038/35077232 · Cited by 3,939
DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
Bakkenist, C. J., & Kastan, M. B. (2003) · Nature · doi:10.1038/nature01368 · Cited by 3,466
Cell-cycle checkpoints and cancer
Kastan, M. B., & Bartek, J. (2004) · Nature · doi:10.1038/nature03097 · Cited by 2,836
ATM and related protein kinases: safeguarding genome integrity
Shiloh, Y. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1011 · Cited by 2,577
Poly(ADP-ribose): novel functions for an old molecule
Schreiber, V., Dantzer, F., Amé, J., & de MURCIA, G. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1963 · Cited by 1,975
The DNA Damage Response: Ten Years After
Harper, J. W., & Elledge, S. J. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.11.015 · Cited by 1,705
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 280
Hou, J., Yun, Y. J., Xue, J., Jeon, B.-M., & Kim, S. (2020) · Phytotherapy Research · doi:10.1002/ptr.6636 · Cited by 53
The Multifactorial Role of PARP-1 in Tumor Microenvironment
Martí, J. M., Fernández‐Cortés, M., Serrano-Sáenz, S., Zamudio-Martínez, E., Delgado‐Bellido, D., García-Díaz, Á., & Oliver, F. J. (2020) · Cancers · doi:10.3390/cancers12030739 · Cited by 55
Innate immune response orchestrates phosphoribosyl pyrophosphate synthetases to support DNA repair
Liu, R. R., Li, J., Shao, J., Lee, J.-H., Qiu, X., Xiao, Y., Zhang, B., Hao, Y., Li, M., & Chen, Q. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.07.009 · Cited by 49
TAK1 inhibitor 5Z-7-oxozeaenol sensitizes neuroblastoma to chemotherapy
Fan, Y., Cheng, J., Vasudevan, S. A., Patel, R. H., Li, L., Xu, X. Y., Zhao, Y., Jia, W., Lu, F., Zhang, H., et al. (2013) · APOPTOSIS · doi:10.1007/s10495-013-0864-0 · Cited by 49
Elevated A20 contributes to age-dependent macrophage dysfunction in the lungs
Hinojosa, C. A., Babu, R. A. S., Rahman, M. M., Fernandes, G., Boyd, A. R., & Orihuela, C. J. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.01.007 · Cited by 49
Wang, W., Zhang, B., Mani, A. M., Wu, Z., Yu, F., Li, W., & Wu, Z. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.249151 · Cited by 49
Cho, E.-A., Kim, E., Kwak, S.-J., & Juhnn, Y. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-36 · Cited by 47
Cheng, X. F., Yao, X., Xu, S., Pan, J., Yu, H., Bao, J., Guan, H., Lu, R., & Zhang, L. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.074 · Cited by 47
Monitoring the Levels of Cellular NF-κB Activation States
Meier‐Soelch, J., Mayr‐Buro, C., Juli, J. U., Leib, L., Linne, U., Dreute, J., Papantonis, A., Schmitz, M. L., & Kracht, M. (2021) · Cancers · doi:10.3390/cancers13215351 · Cited by 53
Pratelli, R., Guerra, D. D., Shi, Y., Wogulis, M. D., Kraft, E., Frommer, W. B., Callis, J., & Pilot, G. (2012) · PLANT PHYSIOLOGY · doi:10.1104/pp.111.191965 · Cited by 45
Alexander, E., Hildebrand, D. G., Kriebs, A., Obermayer, K., Manz, M., Rothfuss, O. C., Eßmann, F., & Schulze‐Osthoff, K. (2013) · Journal of Cell Science · doi:10.1242/jcs.128835 · Cited by 47
TAK1 ubiquitination regulates doxorubicin-induced NF-κB activation
Liang, L., Fan, Y., Cheng, J., Cheng, D., Zhao, Y., Cao, B., Ma, L., An, L., Jia, W., Xu, S., et al. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.09.003 · Cited by 44
Wu, Y.-H., Wu, W.-S., Lin, L.-C., Liu, C.-S., Ho, S., Wang, B.-J., Huang, B., Yeh, Y.-L., Chiu, H., Yang, W.-L., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0760-0 · Cited by 42
Zheng, L., Su, J., Zhang, Z., Jiang, L., Wei, J., Xu, X., & Lv, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-77448-6 · Cited by 42
Sabatel, H., Valentin, E. D., Gloire, G., Dequiedt, F., Piette, J. G., & Habraken, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038246 · Cited by 40
The Inhibitor of Apoptosis (IAPs) in Adaptive Response to Cellular Stress
Marivin, A., Berthelet, J., Plenchette, S., & Dubrez, L. (2012) · Cells · doi:10.3390/cells1040711 · Cited by 42
Proteomic techniques to probe the ubiquitin landscape
Beaudette, P., Popp, O., & Dittmar, G. (2015) · PROTEOMICS · doi:10.1002/pmic.201500290 · Cited by 43
Self-citationTSG101 associates with PARP1 and is essential for PARylation and DNA damage‐induced NF‐κB activation
Tufan, A. B., Lazarow, K., Kolesnichenko, M., Sporbert, A., von Kries, J. P., & Scheidereit, C. (2022) · The EMBO Journal · doi:10.15252/embj.2021110372 · Cited by 40
Self-citationImportance of PIKKs in NF-κB activation by genotoxic stress
Sabatel, H., Pirlot, C., Piette, J. G., & Habraken, Y. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.105 · Cited by 39
Inside-Out Signaling Pathways from Nuclear Reactive Oxygen Species Control Pulmonary Innate Immunity
Choudhary, S., Boldogh, I. R., & Brasier, A. R. (2016) · Journal of Innate Immunity · doi:10.1159/000442254 · Cited by 39
Inhibitor of Apoptosis (IAP) proteins as therapeutic targets for radiosensitization of human cancers
Fulda, S. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.01.005 · Cited by 40
The crosstalk between DNA-damage responses and innate immunity
He, M., Jiang, H., Li, S., Xue, M., Wang, H., Zheng, C., & Tong, J. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112768 · Cited by 41
Chen, Y., Tang, C. S., Zhang, M., Huang, W., Xu, Y. K., Sun, H.-Y., Yang, F., Song, L., Wang, H., Mu, L., et al. (2019) · Leukemia · doi:10.1038/s41375-019-0458-0 · Cited by 37
Lala-Tabbert, N., Mrad, R. L., Timusk, K., Fukano, M., Holbrook, J., St-Jean, M., LaCasse, E. C., & Korneluk, R. G. (2019) · Skeletal Muscle · doi:10.1186/s13395-019-0201-6 · Cited by 37
Martin, S. E., Wu, Z., Gehlhaus, K., Jones, T. L., Zhang, Y., Guha, R., Miyamoto, S., Pommier, Y. G., & Caplen, N. J. (2011) · Current Cancer Drug Targets · doi:10.2174/156800911797264734 · Cited by 36
Zhang, D., Liu, C., Li, H., & Jiao, J. (2020) · Advanced Science · doi:10.1002/advs.202002117 · Cited by 35
González, J. B., Auclair, S., Luan, S., Thomas, L., Atkins, K. M., Aslan, J. E., Thomas, L., Zhao, J., Zhao, Y., & Thomas, G. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.23 · Cited by 34
A serum protein signature of APOE genotypes in centenarians
Sebastiani, P., Monti, S., Morris, M. K., Gurinovich, A., Tanaka, T., Andersen, S. L., Sweigart, B., Ferrucci, L., Jennings, L. L., Glass, D. J., et al. (2019) · Aging Cell · doi:10.1111/acel.13023 · Cited by 30
ATM inhibition enhance immunotherapy by activating STING signaling and augmenting MHC Class I
Li, C., Wang, B., Tu, J., Liu, C., Wang, Y., Chen, J., Huang, Y., Liu, B., & Yuan, X. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06911-3 · Cited by 35
Xu, R., Liu, R.-Y., Wu, C., Zhao, Y., Yang, L., Yao, Y., & Xu, Y. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000369748 · Cited by 34
Chen, Z., Cao, Z., Zhang, W., Gu, M., Zhou, Z., Li, B., Li, J., Tan, E., & Zeng, L. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx337 · Cited by 34
The IκB kinase complex is a regulator of mRNA stability
Mikuda, N., Kolesnichenko, M., Beaudette, P., Popp, O., Uyar, B., Sun, W., Tufan, A. B., Perder, B., Akalin, A., Chen, W., et al. (2018) · The EMBO Journal · doi:10.15252/embj.201798658 · Cited by 35
Self-citationFerlazzo, M. L., Berthel, É., Granzotto, A., Devic, C., Sonzogni, L., Bachelet, J.-T., Pereira, S., Bourguignon, M., Sarasin, A. R., Mezzina, M., et al. (2019) · International Journal of Radiation Biology · doi:10.1080/09553002.2020.1694189 · Cited by 33
Function of microRNA‑124 in the pathogenesis of cancer (Review)
Liu, Y., Yang, Y., Wang, X., Yin, S., Liang, B., Zhang, Y., Fan, M., Fu, Z., Shen, C., Han, Y., et al. (2023) · International Journal of Oncology · doi:10.3892/ijo.2023.5594 · Cited by 34
Effect of longevity genetic variants on the molecular aging rate
Gurinovich, A., Song, Z., Zhang, W., Federico, A. N., Monti, S., Andersen, S. L., Jennings, L. L., Glass, D. J., Barzilai, N., Milman, S., et al. (2021) · GeroScience · doi:10.1007/s11357-021-00376-4 · Cited by 28
Coordinated regulation of plant immunity by poly(ADP-ribosyl)ation and K63-linked ubiquitination
Yao, D., Arguez, M. A., He, P., Bent, A. F., & Song, J. (2021) · Molecular Plant · doi:10.1016/j.molp.2021.08.013 · Cited by 30
ATM Modulates Nuclear Mechanics by Regulating Lamin A Levels
Shah, P., McGuigan, C. W., Cheng, S., Vanpouille‐Box, C., Demaria, S., Weiss, R. S., & Lammerding, J. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.875132 · Cited by 33
Janus, P., Szołtysek, K., Zając, G., Stokowy, T., Walaszczyk, A., Widłak, W., Wojtaś, B., Gielniewski, B., Iwanaszko, M., Braun, R., et al. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2018.02.011 · Cited by 31
POPX2 phosphatase regulates apoptosis through the TAK1-IKK-NF-κB pathway
Weng, T., & Koh, C.-G. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.443 · Cited by 29
Meng, Y., Liu, C., Shen, L., Zhou, M., Liu, W., Kowolik, C. M., Campbell, J. L., Zheng, L., & Shen, B. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz537 · Cited by 29
Move or Die: the Fate of the Tax Oncoprotein of HTLV-1
Lodewick, J., Lamsoul, I., & Bex, F. (2011) · Viruses · doi:10.3390/v3060829 · Cited by 29
Magyar, K., Deres, L., Erős, K., Bruszt, K., Seress, L., Hamar, J., Hideg, K., Balogh, A., Gallyas, F., Sümegi, B., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.03.008 · Cited by 28
P53-induced protein with a death domain (PIDD): master of puppets?
Bock, F. J., Peintner, L., Tanzer, M. C., Manzl, C., & Villunger, A. (2012) · Oncogene · doi:10.1038/onc.2011.639 · Cited by 29
Viral Modulation of the DNA Damage Response and Innate Immunity: Two Sides of the Same Coin
Lopez, A., Doyle, R. N., Sandoval, C., Nisson, K., Yang, V. B., & Fregoso, O. I. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167327 · Cited by 31
Jat, P., Perkins, N. D., & Mowla, S. N. (2013) · OncoTargets and Therapy · doi:10.2147/ott.s36160 · Cited by 33
Medunjanin, S., Putzier, M., Nöthen, T., Weinert, S., Kähne, T., Luani, B., Zuschratter, W., & Braun-Dullaeus, R. C. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03411-y · Cited by 28
RSK2 is required for TRAF6 phosphorylation-mediated colon inflammation
Yao, K., Lee, S., Peng, C., Lim, D. Y., Yamamoto, H., Ryu, J., Lim, T., Chen, H., Jin, G., Zhao, Z., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0167-6 · Cited by 27
Deciphering the Role of Innate Immune NF-ĸB Pathway in Pancreatic Cancer
Khurana, N., Dodhiawala, P. B., Bulle, A. S., & Lim, K. (2020) · Cancers · doi:10.3390/cancers12092675 · Cited by 27
Crosstalk between cGAS-STING pathway and autophagy in cancer immunity
Lu, Q., Chen, Y., Li, J., Zhu, F., & Zheng, Z. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1139595 · Cited by 28
ATM-Mediated DNA Damage Signals Mediate Immune Escape through Integrin-αvβ3–Dependent Mechanisms
Jinushi, M., Chiba, S., Baghdadi, M., Kinoshita, I., Dosaka‐Akita, H., Ito, K., Yoshiyama, H., Yagita∥, H., Uede, T., & Takaoka, A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2028 · Cited by 27
Pro-apoptotic functions of TRAF2 in p53-mediated apoptosis induced by cisplatin
Tsuchida, M., Yokosawa, T., Noguchi, T., Shimada, T., Yamada, M., Sekiguchi, Y., Hirata, Y., & Matsuzawa, A. (2020) · The Journal of Toxicological Sciences · doi:10.2131/jts.45.219 · Cited by 27
Bock, F. J., Krumschnabel, G., Manzl, C., Peintner, L., Tanzer, M. C., Hermann‐Kleiter, N., Baier, G., Llacuna, L., Yélamos, J., & Villunger, A. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.152 · Cited by 27
PARP inhibition and postinfarction myocardial remodeling
Halmosi, R., Deres, L., Gál, R., Erős, K., Sümegi, B., & Tóth, K. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.06.223 · Cited by 28
HOXC10 promotes gastric cancer cell invasion and migration via regulation of the NF-κB pathway
Yao, S., He, L., Zhang, Y., Ye, L., Lai, Y., Huang, L., Wu, L., Wu, G., & Zhu, S. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.05.019 · Cited by 26
Chen, T., Wang, W., Li, J., Xu, H., Peng, Y., Fan, L., Yan, F., Gu, C., Wang, L., & Chen, G. (2016) · Brain Research · doi:10.1016/j.brainres.2016.05.005 · Cited by 25
Sub-cellular localization specific SUMOylation in the heart
Le, N., Martin, J. F., Fujiwara, K., & Abe, J. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.01.018 · Cited by 25
Bound, N. T., Vandenberg, C. J., Kartikasari, A. E. R., Plebanski, M., & Scott, C. L. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.886170 · Cited by 30
TAK1 inhibitor 5Z-7-oxozeaenol sensitizes cervical cancer to doxorubicin-induced apoptosis
Guan, S., Lu, J., Zhao, Y., Woodfield, S. E., Zhang, H., Xu, X. Y., Yu, Y., Zhao, J., Bieerkehazhi, S., Liang, H., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16895 · Cited by 25
Non‐canonical ATM/MRN activities temporally define the senescence secretory program
Malaquin, N., Carrier-Leclerc, A., Martinez, A., Dessureault, M., Ghadaouia, S., Coppé, J., Nadeau, S., Cardin, G., Campisi, J., & Rodier, F. (2020) · EMBO Reports · doi:10.15252/embr.202050718 · Cited by 25
ADP‐ribosylation in evasion, promotion and exacerbation of immune responses
Rosado, M. M., & Pioli, C. (2021) · Immunology · doi:10.1111/imm.13332 · Cited by 24
Promotion of DNA repair by nuclear IKKβ phosphorylation of ATM in response to genotoxic stimuli
Sakamoto, K., Hikiba, Y., Nakagawa, H., Hirata, Y., Hayakawa, Y., Kinoshita, H., Nakata, W., Sakitani, K., Takahashi, R., Akanuma, M., et al. (2012) · Oncogene · doi:10.1038/onc.2012.192 · Cited by 24
Dittmar, G., & Selbach, M. (2014) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201400112 · Cited by 27
Self-citationSuzuki, M., Asai, Y., Kagi, T., Noguchi, T., Yamada, M., Hirata, Y., & Matsuzawa, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249497 · Cited by 23
Kaur, G., Singh, N., Lingeshwar, P., Siddiqui, H. H., & Hanif, K. (2014) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2014.11.004 · Cited by 23
Aspects of innate immunity and Parkinson's disease
Huang, Y., & Halliday, G. M. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00033 · Cited by 22
Campos‐Sánchez, J. C., Mayor-Lafuente, J., Guardiola, F. A., & Esteban, M. Á. (2021) · Fish Physiology and Biochemistry · doi:10.1007/s10695-021-00999-6 · Cited by 22
Gutierrez‐Quintana, R., Walker, D. J., Williams, K. J., Forster, D. M., & Chalmers, A. J. (2022) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdab190 · Cited by 22
The Killer’s Web: Interconnection between Inflammation, Epigenetics and Nutrition in Cancer
Mecca, M., Picerno, S., & Cortellino, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052750 · Cited by 24
Alternative nuclear functions for NF-κB family members.
Espinosa, L., Bigas, A., & Mulero, M. C. (2011) · Europe PMC (PubMed Central) · Cited by 22
NAD+ Degrading Enzymes, Evidence for Roles During Infection
Tan, A., & Doig, C. L. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.697359 · Cited by 23
Li, S., Wang, J., Lu, Y., Zhao, Y., Prinz, R. A., & Xu, X. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03744-2 · Cited by 21
ADP-Ribosylated Peptide Enrichment and Site Identification: The Phosphodiesterase-Based Method
Daniels, C. M., Ong, S., & Leung, A. K. L. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6993-7_7 · Cited by 21
Oxygen sensing is impaired in ATM-defective cells
Mongiardi, M. P., Stagni, V., Natoli, M., Giaccari, D., D’Agnano, I., Falchetti, M. L., Barilà, D., & Levi, A. (2011) · Cell Cycle · doi:10.4161/cc.10.24.18663 · Cited by 20
A systematic approach to decipher crosstalk in the p53 signaling pathway using single cell dynamics
Konrath, F., Mittermeier, A., Cristiano, E., Wolf, J., & Loewer, A. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007901 · Cited by 20
Elmongy, E. I., Attallah, N. G. M., Altwaijry, N., AlKahtani, M. M., & Henidi, H. A. (2021) · Molecules · doi:10.3390/molecules27010123 · Cited by 20
Wu, Z., Wang, C., Bai, M., Li, X., Mei, Q., Li, X., Wang, Y., Fu, X., Luo, G., & Han, W. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv161 · Cited by 21
Zhang, S., Pan, D., Jia, X.-M., Lin, X., & Zhao, X. (2017) · Protein & Cell · doi:10.1007/s13238-017-0441-3 · Cited by 19
Hwang, B., McCool, K. W., Wan, J., Wuerzberger‐Davis, S. M., Young, E. W. K., Choi, E. Y., Cingolani, G., Weaver, B. A. A., & Miyamoto, S. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.645960 · Cited by 20
Nagane, M., Yasui, H., Sakai, Y., Yamamori, T., Niwa, K., Hattori, Y., Kondo, T., & Inanami, O. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.12.002 · Cited by 19
Yamaguchi, N., Yokota, M., Taguchi, Y., Gohda, J., & Inoue, J. (2012) · Genes to Cells · doi:10.1111/gtc.12012 · Cited by 18
Modulation of inflammation and disease tolerance by DNA damage response pathways
Neves‐Costa, A., & Moita, L. F. (2016) · FEBS Journal · doi:10.1111/febs.13910 · Cited by 20
Peng, C., Zhu, F., Wen, W., Yao, K., Li, S., Zykova, T. A., Liu, K., Li, X., Ma, W., Bode, A. M., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.359521 · Cited by 18
Wang, J., Liu, K., Xiao, T.-X., Liu, P.-G., Prinz, R., & Xu, X. (2022) · Oncoimmunology · doi:10.1080/2162402x.2021.2016159 · Cited by 16
Priester, J., Dreute, J., Kracht, M., & Schmitz, M. L. (2022) · Biomedicines · doi:10.3390/biomedicines10092108 · Cited by 19
Xia, J., Chen, M., Shao, H., Chen, H., Zhu, S., Zhao, M., Luo, W., Yang, J., & Wu, S. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2812356 · Cited by 17
Deng, S., Wang, J., Hu, Y., Sun, Y., Yang, X., Zhang, B., Deng, Y., Wei, W., Zhang, Z., Wen, L., et al. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216898 · Cited by 20
Wenzel, M., Wunderlich, M. T., Besch, R., Poeck, H., Willms, S., Schwantes, A., Kremer, M., Sutter, G., Endres, S., Schmidt, A., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100523 · Cited by 17
Riedlinger, T., Haas, J., Busch, J., van de Sluis, B., Kracht, M., & Schmitz, M. L. (2018) · Biomedicines · doi:10.3390/biomedicines6010036 · Cited by 18
ATM and IRAK1 orchestrate two distinct mechanisms of NF-κB activation in response to DNA damage
Bournique, E., Sanchez, A., Oh, S., Ghazarian, D., Mahieu, A. L., Manjunath, L., Ednacot, E. M. Q., Ortega, P., Masri, S., Marazzi, I., et al. (2025) · Nature Structural & Molecular Biology · doi:10.1038/s41594-024-01417-0 · Cited by 20
Li, M., Li, L., Asemota, S., Kakhniashvili, D. G., Narayanan, R., Wang, X., & Liao, F. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2123097119 · Cited by 16
Shao, L., Wu, L., & Zhou, D. (2012) · PubMed · doi:10.3978/j.issn.2218-676x.2012.05.04 · Cited by 16
Huang, W. G., Liang, Y., Dong, J., Zhou, L., Gao, C., Jiang, C., Chen, M., Long, Y., & Xu, Y. (2017) · Mediators of Inflammation · doi:10.1155/2017/1685194 · Cited by 16
Lakhdar, I. M., Ferlazzo, M. L., Al-Choboq, J., Berthel, É., Sonzogni, L., Devic, C., Granzotto, A., Thariat, J., & Foray, N. (2020) · Current Eye Research · doi:10.1080/02713683.2020.1808998 · Cited by 15
Riedlinger, T., Bartkuhn, M., Zimmermann, T., Hake, S. B., Nist, A., Stiewe, T., Kracht, M., & Schmitz, M. L. (2019) · Cancers · doi:10.3390/cancers11060883 · Cited by 14
Innate Immune-Directed NF-κB Signaling Requires Site-Specific NEMO Ubiquitination
Jun, J., Kertesy, S. B., Jones, M. B., Marinis, J. M., Cobb, B. A., Tigno-Aranjuez, J. T., & Abbott, D. W. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.06.036 · Cited by 15
TAK1 Inhibitor Enhances the Therapeutic Treatment for Glioblastoma
Campolo, M., Lanza, M., Casili, G., Paterniti, I., Filippone, A., Caffo, M., Cardali, S. M., Puliafito, I., Colarossi, C., Raciti, G., et al. (2020) · Cancers · doi:10.3390/cancers13010041 · Cited by 14
Cezanne Paints Inflammation by Regulating Ubiquitination
Abe, J., & Berk, B. C. (2013) · Circulation Research · doi:10.1161/circresaha.113.301518 · Cited by 14
Regulation of cellular senescence by innate immunity
Hou, J., Zheng, Y., & Gao, C. (2023) · Biophysics Reports · doi:10.52601/bpr.2023.230032 · Cited by 17
The role of the DNA damage response kinase ataxia telangiectasia mutated in neuroprotection.
Marinoglou, K. (2012) · Europe PMC (PubMed Central) · Cited by 13
CLK2 and CLK4 are regulators of DNA damage-induced NF-κB targeted by novel small molecule inhibitors
Mucka, P., Lindemann, P., Bosco, B., Willenbrock, M., Radetzki, S., Neuenschwander, M., Brischetto, C., von Kries, J. P., Nazaré, M., & Scheidereit, C. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.06.027 · Cited by 13
Self-citation
Metadata
- Authors
- Hinz, M., Stilmann, M., Arslan, S. Ç., Khanna, K. K., Dittmar, G., & Scheidereit, C.
- Affiliations
- Max Delbrück Center (DE)
- QIMR Berghofer Medical Research Institute (AU)
- Corresponding author
- Scheidereit, Claus
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 2010-10
- Volume
- 40
- Issue
- 1
- Pages
- 63-74
- ISSN
- 1097-2765 (ISSN-L)
- OpenAlex
- W2083922442
- Cited by
- 280
- References
- 42
- Citations by year
- 2026: 11 · 2025: 7 · 2024: 17 · 2023: 10 · 2022: 19 · 2021: 21 · 2020: 18 · 2019: 13 · 2018: 16 · 2017: 18 · 2016: 9 · 2015: 12 · 2014: 20 · 2013: 21 · 2012: 44
- FWCI
- 8.97
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 1056 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Molecular Cell (publishedVersion)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- ATM kinase, TRAF6, cIAP1, NF-κB activation, DNA damage signaling, genotoxic stress response, PARP1, K63-linked ubiquitination, Ubc13, SUMOylation, PIASy, TAB2, TAK1, IKK complex
- MeSH terms
- Poly (ADP-Ribose) Polymerase-1, MAP Kinase Kinase Kinase 7, Calcium, Cell Nucleus, Cytosol, DNA Damage, DNA-Binding Proteins, HeLa Cells, Humans, Mutation, Phosphorylation, Poly(ADP-ribose) Polymerases, Protein Binding, Recombinant Proteins, Time Factors, Transfection, Tumor Necrosis Factor-alpha, Signal Transduction, NF-kappa B, Protein Serine-Threonine Kinases, Cell Cycle Proteins, MAP Kinase Kinase Kinases, Protein Transport, Tumor Suppressor Proteins, Ubiquitin, RNA Interference, Ubiquitin-Conjugating Enzymes, Ubiquitin-Protein Ligases, TNF Receptor-Associated Factor 6, Adaptor Proteins, Signal Transducing, Inhibitor of Apoptosis Proteins, I-kappa B Kinase, DNA Breaks, Double-Stranded, Ubiquitination, Hep G2 Cells, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review